{"transactions":[{"id":2041034,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":117508,"kind":"person","name":"Sazdanoff Catherine","position":1,"cik":"0001650901","reported_name":"Sazdanoff Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-31T14:21:33.000Z","date":"2023-01-31","kind":"disposition_to_issuer","acquired":false,"shares":5656,"price":13.25,"value":74942.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F9","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."}],"balance_after":0,"derivative":{"exercise_price":20.75,"expiration_date":"2032-01-26","underlying":"Common Stock","underlying_shares":5656},"source":{"system":"sec-edgar","filing":"0001567619-23-001536","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/794172/000156761923001536/doc1.xml","form_type":"4"}},{"id":2041033,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":117508,"kind":"person","name":"Sazdanoff Catherine","position":1,"cik":"0001650901","reported_name":"Sazdanoff Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-31T14:21:33.000Z","date":"2023-01-31","kind":"disposition_to_issuer","acquired":false,"shares":5796,"price":12.64,"value":73261.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."}],"balance_after":0,"derivative":{"exercise_price":21.36,"expiration_date":"2031-01-27","underlying":"Common Stock","underlying_shares":5796},"source":{"system":"sec-edgar","filing":"0001567619-23-001536","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/794172/000156761923001536/doc1.xml","form_type":"4"}},{"id":2041032,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":117508,"kind":"person","name":"Sazdanoff Catherine","position":1,"cik":"0001650901","reported_name":"Sazdanoff Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-31T14:21:33.000Z","date":"2023-01-31","kind":"disposition_to_issuer","acquired":false,"shares":17205,"price":23.54,"value":405005.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F7","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."}],"balance_after":0,"derivative":{"exercise_price":10.46,"expiration_date":"2030-01-29","underlying":"Common Stock","underlying_shares":17205},"source":{"system":"sec-edgar","filing":"0001567619-23-001536","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/794172/000156761923001536/doc1.xml","form_type":"4"}},{"id":2041031,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":117508,"kind":"person","name":"Sazdanoff Catherine","position":1,"cik":"0001650901","reported_name":"Sazdanoff Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-31T14:21:33.000Z","date":"2023-01-31","kind":"disposition_to_issuer","acquired":false,"shares":8740,"price":17.03,"value":148842.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."}],"balance_after":0,"derivative":{"exercise_price":16.97,"expiration_date":"2029-01-24","underlying":"Common Stock","underlying_shares":8740},"source":{"system":"sec-edgar","filing":"0001567619-23-001536","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/794172/000156761923001536/doc1.xml","form_type":"4"}},{"id":2041030,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":117508,"kind":"person","name":"Sazdanoff Catherine","position":1,"cik":"0001650901","reported_name":"Sazdanoff Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-31T14:21:33.000Z","date":"2023-01-31","kind":"disposition_to_issuer","acquired":false,"shares":12000,"price":17.8,"value":213600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."}],"balance_after":0,"derivative":{"exercise_price":16.2,"expiration_date":"2028-01-25","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001567619-23-001536","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/794172/000156761923001536/doc1.xml","form_type":"4"}},{"id":2041029,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":117508,"kind":"person","name":"Sazdanoff Catherine","position":1,"cik":"0001650901","reported_name":"Sazdanoff Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-31T14:21:33.000Z","date":"2023-01-31","kind":"disposition_to_issuer","acquired":false,"shares":12000,"price":21.2,"value":254400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."}],"balance_after":0,"derivative":{"exercise_price":12.8,"expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001567619-23-001536","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/794172/000156761923001536/doc1.xml","form_type":"4"}},{"id":2041028,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":117508,"kind":"person","name":"Sazdanoff Catherine","position":1,"cik":"0001650901","reported_name":"Sazdanoff Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-31T14:21:33.000Z","date":"2023-01-31","kind":"disposition_to_issuer","acquired":false,"shares":8500,"price":15.36,"value":130560.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."}],"balance_after":0,"derivative":{"exercise_price":18.64,"expiration_date":"2026-01-27","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001567619-23-001536","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/794172/000156761923001536/doc1.xml","form_type":"4"}},{"id":2041027,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":117508,"kind":"person","name":"Sazdanoff Catherine","position":1,"cik":"0001650901","reported_name":"Sazdanoff Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-31T14:21:33.000Z","date":"2023-01-31","kind":"disposition_to_issuer","acquired":false,"shares":8500,"price":15.82,"value":134470.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."}],"balance_after":0,"derivative":{"exercise_price":18.18,"expiration_date":"2025-08-14","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001567619-23-001536","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000156761923001536/doc1.xml","form_type":"4"}},{"id":2041026,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":117508,"kind":"person","name":"Sazdanoff Catherine","position":1,"cik":"0001650901","reported_name":"Sazdanoff Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-31T14:21:33.000Z","date":"2023-01-31","kind":"disposition_to_issuer","acquired":false,"shares":16424,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were disposed of pursuant to the Agreement and Plan of Merger dated as of July 7, 2022 (the \"Merger Agreement\") by and among the Issuer and SD Biosensor, Inc., a corporation with limited liability organized under the laws of the Republic of Korea whereby, immediately prior to the effective time of the merger contemplated therein (the \"Effective Time\"), all issued and outstanding shares of Issuer common stock were converted into the right to receive $34.00 per share in cash and, when so converted, automatically cancelled."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-23-001536","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000156761923001536/doc1.xml","form_type":"4"}},{"id":2423319,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":117508,"kind":"person","name":"Sazdanoff Catherine","position":1,"cik":"0001650901","reported_name":"Sazdanoff Catherine","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2022-01-28T11:43:05.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":5656,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are awarded under the 2021 Omnibus Award Plan and vest in full (100%) on January 25, 2023."}],"balance_after":5656,"derivative":{"exercise_price":20.75,"expiration_date":"2032-01-26","underlying":"Common Stock","underlying_shares":5656},"source":{"system":"sec-edgar","filing":"0001127602-22-002353","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760222002353/form4.xml","form_type":"4"}},{"id":2423318,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":117508,"kind":"person","name":"Sazdanoff Catherine","position":1,"cik":"0001650901","reported_name":"Sazdanoff Catherine","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-01-28T11:43:05.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":3012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are awarded under the 2021 Omnibus Award Plan and vest in full (100%) on January 25, 2023."}],"balance_after":16424,"source":{"system":"sec-edgar","filing":"0001127602-22-002353","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760222002353/form4.xml","form_type":"4"}},{"id":2455954,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":117508,"kind":"person","name":"Sazdanoff Catherine","position":1,"cik":"0001650901","reported_name":"Sazdanoff Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-12-30T18:03:21.000Z","date":"2021-12-29","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/29/2021 and will vest 100% on the one year anniversary of the grant date (Dec 29, 2022) or immediately prior to the next AGM, whichever is sooner."}],"balance_after":29091,"derivative":{"exercise_price":1.32,"expiration_date":"2026-12-28","underlying":"Common shares","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001213900-21-068185","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650901/000121390021068185/ownership.xml","form_type":"4"}},{"id":2891328,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":117508,"kind":"person","name":"Sazdanoff Catherine","position":1,"cik":"0001650901","reported_name":"Sazdanoff Catherine","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2021-01-29T12:11:27.000Z","date":"2021-01-27","kind":"grant","acquired":true,"shares":5796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are awarded under the 2021 Omnibus Award Plan and vest in full (100%) on January 26, 2022."}],"balance_after":5796,"derivative":{"exercise_price":21.36,"expiration_date":"2031-01-27","underlying":"Common Stock","underlying_shares":5796},"source":{"system":"sec-edgar","filing":"0001127602-21-002944","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221002944/form4.xml","form_type":"4"}},{"id":2891327,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":117508,"kind":"person","name":"Sazdanoff Catherine","position":1,"cik":"0001650901","reported_name":"Sazdanoff Catherine","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-01-29T12:11:27.000Z","date":"2021-01-27","kind":"grant","acquired":true,"shares":1545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are awarded under the 2021 Omnibus Award Plan and vest in full (100%) on January 26, 2022."}],"balance_after":13412,"source":{"system":"sec-edgar","filing":"0001127602-21-002944","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221002944/form4.xml","form_type":"4"}},{"id":2937257,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":117508,"kind":"person","name":"Sazdanoff Catherine","position":1,"cik":"0001650901","reported_name":"Sazdanoff Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-18T06:24:07.000Z","date":"2020-12-16","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Canadian exercise price of C$3.85 was converted into U.S. dollars using an exchange rate of C$1.2753 = US$1.00."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options were granted on 12/16/2020 and will vest monthly as follows: 325 vest on 01/16/2021; and 305 vest on the 16th day of each of the following 35 months."}],"balance_after":11000,"derivative":{"exercise_price":3.02,"expiration_date":"2025-12-15","underlying":"Common shares","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001213900-20-043371","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650901/000121390020043371/ownership.xml","form_type":"4"}},{"id":2937256,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":117508,"kind":"person","name":"Sazdanoff Catherine","position":1,"cik":"0001650901","reported_name":"Sazdanoff Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-18T06:24:07.000Z","date":"2020-12-16","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Canadian exercise price of C$3.85 was converted into U.S. dollars using an exchange rate of C$1.2753 = US$1.00."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted on 12/16/2020 and will vest 100% on the one year anniversary of the grant date (Dec 16, 2021) or immediately prior to the next AGM, whichever is sooner."}],"balance_after":7000,"derivative":{"exercise_price":3.02,"expiration_date":"2025-12-15","underlying":"Common shares","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001213900-20-043371","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650901/000121390020043371/ownership.xml","form_type":"4"}},{"id":3297298,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":117508,"kind":"person","name":"Sazdanoff Catherine","position":1,"cik":"0001650901","reported_name":"Sazdanoff Catherine","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2020-01-31T12:34:11.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":17205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are awarded under the 2012 Stock Incentive Plan and vest 25% every 90 days from the date of grant."}],"balance_after":17205,"derivative":{"exercise_price":10.46,"expiration_date":"2030-01-30","underlying":"Common Stock","underlying_shares":17205},"source":{"system":"sec-edgar","filing":"0001127602-20-002838","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760220002838/form4.xml","form_type":"4"}},{"id":3297297,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":117508,"kind":"person","name":"Sazdanoff Catherine","position":1,"cik":"0001650901","reported_name":"Sazdanoff Catherine","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-01-31T12:34:11.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":3186,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are awarded under the 2012 Stock Incentive Plan and vest 25% every 90 days from the date of grant."}],"balance_after":11867,"source":{"system":"sec-edgar","filing":"0001127602-20-002838","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760220002838/form4.xml","form_type":"4"}},{"id":3686086,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":117508,"kind":"person","name":"Sazdanoff Catherine","position":1,"cik":"0001650901","reported_name":"Sazdanoff Catherine","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2019-01-28T11:27:02.000Z","date":"2019-01-24","kind":"grant","acquired":true,"shares":8740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are awarded under the 2012 Stock Incentive Plan and vest 25% every 90 days from the date of grant."}],"balance_after":8740,"derivative":{"exercise_price":16.97,"expiration_date":"2029-01-24","underlying":"Common Stock","underlying_shares":8740},"source":{"system":"sec-edgar","filing":"0001127602-19-002782","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760219002782/form4.xml","form_type":"4"}},{"id":3686085,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":117508,"kind":"person","name":"Sazdanoff Catherine","position":1,"cik":"0001650901","reported_name":"Sazdanoff Catherine","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-01-28T11:27:02.000Z","date":"2019-01-24","kind":"grant","acquired":true,"shares":981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are awarded under the 2012 Stock Incentive Plan and vest 25% every 90 days from the date of grant."}],"balance_after":981,"source":{"system":"sec-edgar","filing":"0001127602-19-002782","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760219002782/form4.xml","form_type":"4"}},{"id":4089105,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":117508,"kind":"person","name":"Sazdanoff Catherine","position":1,"cik":"0001650901","reported_name":"Sazdanoff Catherine","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2018-01-26T14:02:19.000Z","date":"2018-01-25","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests 25% every 90 days from the date of grant."}],"balance_after":12000,"derivative":{"exercise_price":16.2,"expiration_date":"2028-01-25","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001127602-18-002630","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760218002630/form4.xml","form_type":"4"}},{"id":4481155,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":117508,"kind":"person","name":"Sazdanoff Catherine","position":1,"cik":"0001650901","reported_name":"Sazdanoff Catherine","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-26T12:17:53.000Z","date":"2017-01-25","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests 25% every 90 days from the date of grant."}],"balance_after":12000,"derivative":{"exercise_price":12.8,"expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001127602-17-002436","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760217002436/form4.xml","form_type":"4"}}]}